Wave Life Sciences Ltd (NASDAQ: WVE) stock closed at $16.44 on 11/8/24 after a major increase of 10.9%. Trading volume in this advance was normal. The stock has risen 19.9% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
WVE’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Wave Life Sciences has a current Value Trend Rating of C (Low Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Wave Life Sciences has a very low Appreciation Score of 0 but a very high Power Rating of 86, triggering the Low Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment